Abstract
Background: CHO-S cells produce non-anticoagulant heparan sulfate (HS) even when transfected with HS3st1 and NDST2. Results: Golgi targeting of HS3st1 alone in bioengineered CHO-S cells afforded anticoagulant HS. Conclusion: Targeting of HS3st1 to the Golgi ensured its action in biosynthesis and modified the action of other biosynthetic enzymes. Significance: Engineering the production of HS and potentially heparin could provide a safer form of this important anticoagulant drug.
| Original language | English |
|---|---|
| Pages (from-to) | 37308-37318 |
| Number of pages | 11 |
| Journal | Journal of Biological Chemistry |
| Volume | 288 |
| Issue number | 52 |
| DOIs | |
| State | Published - 27 Dec 2013 |
| Externally published | Yes |
Fingerprint
Dive into the research topics of 'Bioengineered chinese hamster ovary cells with golgi-targeted 3-O-sulfotransferase-1 biosynthesize heparan sulfate with an antithrombin-binding site'. Together they form a unique fingerprint.Cite this
- APA
- Author
- BIBTEX
- Harvard
- Standard
- RIS
- Vancouver